rheumatoid%20arthritis
RHEUMATOID ARTHRITIS

Rheumatoid arthritis is a systemic autoimmune rheumatic disorder of unknown etiology.
It is the most common form of inflammatory arthritis.
Patient usually complains of joint pain and/or swelling with morning stiffness that lasts for more than an hour.

Goals of treatment are clinical & radiological remission of disease and to reduce functional limitations & permanent joint damage.

Drug Information

Indication: Acute & chronic treatment of signs & symptoms of osteoarthritis (OA) & RA; ankylosing spondylitis ...

Indication: Management of acute pain in adults & treatment of primary dysmenorrhea. Relief of acute & chronic pain...

Indication: Signs & symptoms of arthritis deformans, periarthritis humero-scapularis, tendinitis, peritendinitis, hume...

Indication: Signs & symptoms & inhibiting the progression of structural damage in moderately to severely active rh...

Dosage: OA 7.5 mg daily, may be increased to 15 mg daily. RA Initially 15 mg daily, may be reduced to 7.5 mg daily. An

Dosage: Adult RA Initially 3 mg/kg IV infusion over 2-hr, followed by additional 3 mg/kg doses at 2 & 6 wk after t

Indication: In combination w/ methotrexate (MTX) for treatment of moderate to severe active rheumatoid arthritis (RA) in a...

Indication: Moderate to severe pain.

Indication: Adult patients w/ moderately to severely active RA who had an inadequate response or intolerance to methotrexa...

Indication: Treatment of early & established, moderate to severe active RA in adult patients, given alone or in combin...

1  /  19
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2015
Dual-energy computed tomography was better than ultrasound in identifying monosodium urate crystal deposition in upper limb joints of patients with acute gouty arthritis, as shown in a study.
01 Nov 2015
Age, gender, diuretics, comorbidities and adherence are associated with gout flares in patients during year one of urate-lowering therapy according to a retrospective cohort study.